A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple Sclerosis
Clinical trial NCT05704361 · RECRUITING
Trial details
- NCT number
- NCT05704361
- Sponsor
- Hoffmann-La Roche
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-11
- Primary completion
- 2027-07-08
- Enrollment
- 119
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.